Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

0K9E

Novartis (0K9E)

Novartis Ag
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0K9E
DateTimeSourceHeadlineSymbolCompany
01/29/202012:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Delivered Strong Sales Growth, Margin Expansion And Breakthrough Innovation Launching Five...LSE:0K9ENovartis Ag
01/29/202012:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Erzielt 2019 Ein Starkes Umsatzwachstum, Margen-steigerungen Und Bahnbrechende Innovatione...LSE:0K9ENovartis Ag
01/29/202012:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis A Réalisé En 2019 Une Forte Croissance De Son Chiffre D'affaires, Une Augmentation De Sa...LSE:0K9ENovartis Ag
01/06/202012:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Completes Tender Offer For All Outstanding Shares Of The Medicines CompanyLSE:0K9ENovartis Ag
12/16/201912:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Provides Update On Luster Phase Iii Studies In Patients With Uncontrolled Gina 4/5 AsthmaLSE:0K9ENovartis Ag
12/05/201912:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Tender Offer For The Medicines Company CommencesLSE:0K9ENovartis Ag
11/24/20192:00PMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis To Acquire The Medicines Company For Usd 9.7 Bn, Adding Inclisiran, A Potentially Transfor...LSE:0K9ENovartis Ag
11/15/20192:06PMUK RegulatoryNOVARTIS AG CHF0.50(REGD) New Novartis Medicine Adakveo(R) (crizanlizumab) Approved By Fda To Reduce Frequency Of Pain Crises...LSE:0K9ENovartis Ag
11/01/20191:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Shows Encouraging Results Versus Humira(R)* From First-of-its-kind Head-to-hea...LSE:0K9ENovartis Ag
10/30/20191:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Announces Avxs-101 Intrathecal Study UpdateLSE:0K9ENovartis Ag
10/22/201912:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Delivered Another Strong Quarter With Double Digit Sales Growth And Core1 Margin Expansion...LSE:0K9ENovartis Ag
10/22/201912:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis, Encore Un Fort Trimestre: Croissance à Deux Chiffres Des Ventes Et Expansion De La Marge...LSE:0K9ENovartis Ag
10/22/201912:00AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Verzeichnet Ein Weiteres Starkes Quartal Mit Zweistelligem Umsatz-wachstum Und Höherer Ke...LSE:0K9ENovartis Ag
10/08/201912:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Receives Fda Approval For Beovu(R), Offering Wet Amd Patients Vision Gains And Greater Flu...LSE:0K9ENovartis Ag
10/02/201912:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Positive 52-week Prevent Data Confirm Cosentyx(R) Efficacy In Addressing Entire Axspa Spec...LSE:0K9ENovartis Ag
09/29/20199:30AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Kisqali(R) Delivers Consistently Superior Overall Survival -- Monaleesa-3 Trial Demonstrat...LSE:0K9ENovartis Ag
09/17/201912:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Cosentyx(R) Positive 16-week Prevent Results Advance Potential New Indication For Patients...LSE:0K9ENovartis Ag
08/30/201912:15AMUK RegulatoryNOVARTIS AG CHF0.50(REGD) Novartis Ofatumumab Demonstrates Superiority Versus Aubagio(R) In Two Head-to-head Phase Iii Multip...LSE:0K9ENovartis Ag
 Showing the most relevant articles for your search:LSE:0K9E